Sernova Corp. announced the appointment of Mr. Frank Holler to its Board of Directors. Holler brings 25 years of success-driven experience in the biopharma and technology sectors to Sernova's board.

He has been directly involved in the founding and development of some of Canada's most successful biopharma companies including ID Biomedical, Angiotech Pharmaceuticals and Xenon Pharmaceuticals. Mr. Holler previously served as President & CEO of Xenon Pharmaceuticals Inc.